Alzheimer's Disease Prevention Trial
Launched by NATIONAL INSTITUTE ON AGING (NIA) · Oct 29, 1999
Trial Information
Current as of March 27, 2025
Completed
Keywords
ClinConnect Summary
PREventing Postmenopausal memory loss and Alzheimer's with Replacement Estrogens (PREPARE) is a double-blind-placebo controlled trial to determine whether estrogen (or estrogen and progesterone) can delay the onset of memory loss or Alzheimer's Disease in elderly women with a family history of the disease.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Healthy women 65 or older with a family history of memory problems not currently on estrogen.
- Exclusion Criteria:
- • Significant neurological impairment
- • Current estrogen use
- • History of breast cancer
Trial Officials
Mary Sano, PhD
Principal Investigator
Icahn School of Medicine at Mount Sinai
About National Institute On Aging (Nia)
The National Institute on Aging (NIA) is a prominent research organization within the National Institutes of Health (NIH) dedicated to advancing our understanding of aging and age-related diseases. Through a robust portfolio of clinical trials, the NIA focuses on innovative research that aims to enhance the health and well-being of older adults. By fostering collaboration among scientists, healthcare professionals, and communities, the NIA seeks to translate research findings into practical solutions that improve the quality of life for aging populations. Their commitment to rigorous scientific inquiry and public health underscores their role as a leader in geriatric research and the pursuit of effective interventions for age-associated conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Irvine, California, United States
Jacksonville, Florida, United States
New York, New York, United States
Ridgewood, New Jersey, United States
Tulsa, Oklahoma, United States
Miami Beach, Florida, United States
White Plains, New York, United States
North Charleston, South Carolina, United States
Birmingham, Alabama, United States
Stamford, Connecticut, United States
Washington, District Of Columbia, United States
Fort Myers, Florida, United States
Pensacola, Florida, United States
Pompano Beach, Florida, United States
Tallahassee, Florida, United States
West Palm Beach, Florida, United States
Baltimore, Maryland, United States
New York, New York, United States
Port Chester, New York, United States
Providence, Rhode Island, United States
Norfolk, Virginia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials